HRQoL Down for GERD With Laryngopharyngeal Reflux

Share this content:
HRQoL Down for GERD With Laryngopharyngeal Reflux
HRQoL Down for GERD With Laryngopharyngeal Reflux

MONDAY, Jan. 9, 2017 (HealthDay News) -- For patients with gastroesophageal reflux disease (GERD), the presence of laryngopharyngeal reflux symptoms (LPR) is associated with reduced health-related quality of life (HRQoL), according to a study published online Jan. 3 in the Journal of Gastroenterology and Hepatology.

Eun Jeong Gong, from the University of Ulsan College of Medicine in Seoul, South Korea, and colleagues examined the impact of LPR symptoms on HRQoL in a sample of 300 Korean patients with GERD. One hundred fifty of the patients had LPR symptoms, as assessed using the reflux symptom index.

The researchers found that patients with GERD and LPR symptoms had lower mean HRQoL (as assessed by the EuroQoL-5 dimensions questionnaire) than those without LPR (0.88 versus 0.91). LPR symptom severity was related to decreased HRQoL and was independent of age, marital status, body mass index, or household income. Patients with GERD and LPR had lower overall satisfaction rate regarding treatment (40.0 versus 69.1 percent). Compared to those without LPR, GERD patients with LPR symptoms had greater sickness-related absent hours per week (0.36 versus 0.02 hours) and greater percentages of overall work impairment (31.1 versus 20.8 percent).

"GERD patients with LPR symptoms have a poorer HRQoL, a lower satisfaction rate, and a greater disease burden than those without LPR," the authors write.

The study was funded by a grant from Dong-A ST.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »